SCHEMBL24475673

SCHEMBL24475673

c1ccc(-c2cc(-c3ccccn3)cc(-c3ccc4ccc(-c5ccc6ccc(-c7ccc8ccc9cccnc9c8n7)nc6c5)cc4n3)c2)nc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.42
LMNA P02545 3/20 0.42
TP53 P04637 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
HSP90AA1 P07900 2/20 0.42
ALOX15 P16050 2/20 0.42
CCR1 P32246 2/20 0.42
HTT P42858 2/20 0.42
CCR5 P51681 2/20 0.42
CCR8 P51685 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
MAPT P10636 2/20 0.42
TSHR P16473 2/20 0.42
GMNN O75496 1/20 0.42
MMP2 P08253 1/20 0.42
MMP9 P14780 1/20 0.42
NFKB1 P19838 1/20 0.42
MMP8 P22894 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24454307 0.97 KDM4E (0.40) KDM4ELMNATP53SMN1; SMN2CYP3A4
SCHEMBL24475626 0.97 KDM4E (0.42) KDM4ELMNATP53SMN1; SMN2CYP3A4
SCHEMBL24475412 0.95 NPC1 (0.43) KDM4ELMNATP53SMN1; SMN2CYP3A4
SCHEMBL24475447 0.95 TOP1 (0.42) KDM4ELMNATP53SMN1; SMN2CYP3A4
SCHEMBL24453778 0.95 KDM4E (0.40) KDM4ELMNATP53SMN1; SMN2CYP3A4
SCHEMBL24475484 0.94 TOP1 (0.43) KDM4ELMNATP53SMN1; SMN2CYP3A4
SCHEMBL22281848 0.93 LMNA (0.46) KDM4ELMNATP53SMN1; SMN2CYP3A4
SCHEMBL24475512 0.93 NPC1 (0.43) KDM4ELMNATP53SMN1; SMN2CYP3A4
SCHEMBL24453782 0.92 TOP1 (0.42) KDM4ELMNATP53SMN1; SMN2CYP3A4
SCHEMBL24475617 0.92 TOP1 (0.42) KDM4ELMNATP53SMN1; SMN2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220173329-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE LT MATERIALS CO., LTD. (KR) 2022-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220173329-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE OXER1, OCIAD1, OR10J3 KDM4E 3814/4885LMNA 4856/4885TP53 4851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.